Thursday - March 21, 2019
Aerie Pharmaceuticals Assigned Patent for Dual Mechanism Inhibitors
Copyright © Targeted News Service, 2019
2019-01-10
ALEXANDRIA, Va., Jan. 10 -- Aerie Pharmaceuticals, Durham, North Carolina, has been assigned a patent (No. 10,174,017, initially filed March 16, 2018) developed by three co-inventors for "dual mechanism inhibitors for the treatment of disease." The co-inventors are Mitchell A. deLong, Chapel Hill, North Carolina, Jill M. Sturdivant, Chapel Hill, North Carolina, and Susan M. Royalty, Davis, California.

The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Par . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information or a free trial

Copyright Targeted News Service 2019